Luis C. Pinheiro
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance.
Journal: Clinical pharmacology and therapeutics
Published: March 05, 2026
Standardised and Reproducible Phenotyping Using Distributed Analytics and Tools in the Data Analysis and Real World Interrogation Network (DARWIN EU).
Journal: Pharmacoepidemiology and drug safety
Published: January 10, 2024
Artificial intelligence in European medicines regulation.
Journal: Nature reviews. Drug discovery
Published: November 21, 2022
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.
Journal: Pharmacoepidemiology and drug safety
Published: July 27, 2022
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice.
Journal: British journal of clinical pharmacology
Published: November 11, 2021
Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study.
Journal: Clinical drug investigation
Published: February 07, 2019
Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study.
Journal: Clinical drug investigation
Published: November 23, 2018
Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.
Journal: Clinical drug investigation
Published: August 26, 2018
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General Practice.
Journal: Drug safety
Published: May 23, 2018
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance.
Journal: Pharmacoepidemiology and drug safety
Published: April 03, 2017
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance.
Journal: Pharmacoepidemiology and drug safety
Published: December 14, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026